Trupanion, Inc. TRUP has been benefiting from a focus on pet health and well-being in an underpenetrated pet insurance market, product launches, extended operating boundaries, as well as sufficient liquidity. Growth Projections The Zacks Consensus Estimate for Trupanion’s 2024 earnings per share indicates an increase of 57.4% from the year-ago reported number. The consensus estimate for revenues is pegged at $1.26 billion, implying a year-over-year improvement of 13.7%. The consensus estimate for 2025 earnings per share and revenues indicates an increase of 95.4% and 6.5%, respectively, from the corresponding 2024 estimates. The expected long-term earnings growth rate is 39.3% compared with the industry average of 17.1%. Zacks Rank & Price Performance Trupanion currently carries a Zacks Rank #3 (Hold). Over the past year, the stock has gained 4.9% compared with the industry’s growth of 21.6%. Zacks Investment Research Image Source: Zacks Investment Research Earnings Surprise History Trupanion has a decent earnings surprise history. Its earnings beat estimates in each of the trailing four quarters, delivering an average surprise of 43.13%. Business Tailwinds This provider of insurance for cats and dogs operates in a large but underpenetrated market. Management noted that less than 5% of the pets are insured in North America and a very low number across most of Europe. There is immense scope as there has been a change in the attitude of pet owners, who are increasingly focusing on pet health and well-being. TRUP is well poised for growth in a total addressable market worth $34.1 billion. The insurer envisions doubling its addressable market (defined by the number of veterinary hospitals) by the end of 2030. Average monthly retention continues to be strong, ensuring uninterrupted revenue generation. The insurer has also been expanding globally as part of its five-year growth plan, apart from strengthening its compelling portfolio. TRUP noticed increasing contributions from European endeavors, which added about 14,400 new pets during 2023. Its focus on introducing products bodes well for growth. Its portfolio of products comprising Chewy and Aflac, medium and low average monthly revenue per unit products Firkin and Phi Direct and products in continental Europe contributed 22% to gross new pet adds in the first quarter of 2024. Over the long term, TRUP remains focused on growing adjusted operating income and deploying increasing amounts at high internal rates of return. The pet insurer’s five-year plan includes a 15% adjusted operating margin. TRUP projects revenues in the range of $1.2 billion to $1.3 billion, up 14% from the 2023 level. Subscription revenues are projected between $842 million and $862 million, up 20% from 2023. Total adjusted operating income is now expected to be in the range of $100 million to $120 million, up 32% year over year. A solid balance sheet supports investment in new product development and international expansion. Trupanion expects these investments to expand the addressable market in the long run. TRUP has a Growth Score of A. This style score helps analyze the growth prospects of a company. Headwinds However, Trupanion has been incurring higher expenses over the last several years, attributable to an increase in technology and development, general and administrative, new pet acquisition expenses, depreciation and amortization. The insurer must strive to generate revenue growth higher than the rise in the magnitude of expense, or else the margin will continue to erode. Stocks to Consider Some better-ranked stocks from the insurance industry are Reinsurance Group of America, Incorporated RGA, RLI Corp. RLI and NMI Holdings Inc NMIH, each carrying a Zacks Rank #2 (Buy) at present. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here. Reinsurance Group has a solid track record of beating earnings estimates in each of the trailing four quarters, the average being 19.48%. In the past year, shares of RGA have jumped 43.1%.The Zacks Consensus Estimate for RGA’s 2024 and 2025 earnings implies year-over-year growth of 5.3% and 4.9%, respectively. RLI’s earnings surpassed estimates in three of the last four quarters and missed in one, the average surprise being 132.39%. In the past year, shares of RLI have gained 1.9%.The Zacks Consensus Estimate for RLI’s 2024 and 2025 revenues implies year-over-year growth of 18.4% and 3.8%, respectively. NMI Holdings’ earnings surpassed estimates in each of the last four quarters, the average surprise being 8.60%. In the past year, shares of NMIH have jumped 32.5%.The Zacks Consensus Estimate for NMIH’s 2024 and 2025 revenues implies year-over-year growth of 10.6% and 7.6%, respectively. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report RLI Corp. (RLI):Free Stock Analysis Report Reinsurance Group of America, Incorporated (RGA):Free Stock Analysis Report NMI Holdings Inc (NMIH):Free Stock Analysis Report Trupanion, Inc. (TRUP):Free Stock Analysis Report To read this article on Zacks.com click here. Zacks Investment Research
Should You Retain Trupanion (TRUP) Stock in Your Portfolio?
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more
Start Your Free Trial Now!Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...